GeoVax Labs Inc - Company Profile
Powered by
All the data and insights you need on GeoVax Labs Inc in one report.
- Save hours of research time and resources with
our up-to-date GeoVax Labs Inc Strategy Report
- Understand GeoVax Labs Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
GeoVax Labs Insights
Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.
A sample of GeoVax Labs Insights data
Headline | Published | Journalists |
---|---|---|
Deserunt mollit sunt Lorem laborum do id aliqua dolore | 18 Sep 2020 | Lorem |
GeoVax seeks CROs, CMOs in near term for preclinical infectious disease vaccines; seeking to raise up to USD 25m – exec | 02 Jun 2016 | Alissa Fleck |
GeoVax aims to raise USD 5m, including funds for CMOs and contract laboratories on Ebola vaccine - CEO | 30 Oct 2014 | Natalie Morrison |
GSK and NewLink’s respective Ebola vaccines hold promise despite limited clinical data – experts | 06 Oct 2014 | Jinan Harb |
Feature
Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.
Benefit
Drug Insights:
- Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
- Material intelligence on competitors, including breaking news
- Insight on companies’ business development needs and strategies
Outsourcing Insights:
Insight on companies’ CRO and business development needs, strategies and relationships
Value
Remove risk and uncertainty
Gain a competitive edge
Secure actionable leads
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer